| Previous Close | 391.40 |
| Open | 392.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 389.60 - 395.95 |
| 52 Week Range | 269.30 - 395.95 |
| Volume | 646,109 |
| Avg. Volume | 356,091 |
| Market Cap | 218.828B |
| Beta (5Y Monthly) | 0.47 |
| PE Ratio (TTM) | 61.56 |
| EPS (TTM) | 6.34 |
| Earnings Date | Jul. 28, 2021 - Aug. 02, 2021 |
| Forward Dividend & Yield | 4.00 (1.03%) |
| Ex-Dividend Date | Apr. 27, 2021 |
| 1y Target Est | 205.31 |
- GlobeNewswire
L'OREAL: Disclosure of total number of voting rights and number of shares in the capital at May 31th, 2021
Société anonyme au capital de 112 133 283 euros Siège social : 14, rue Royale, 75008 Paris 632 012 100 R.C.S. Paris Legal Entity Identifyer : 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of shares in the capital at 31 May 2021 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares 560,666,415 Number of real voting rights (excluding treasury shares) 559,166,415 Theoretical number of voting
- Reuters
Blue hair hues signal bold make-up revival for new L'Oreal boss
L'Oreal's make-up sales are set to bounce back to pre-COVID-19 pandemic levels, the French group's new chief executive said on Friday, with women opting for brighter colours in their post-crisis makeovers. Nicolas Hieronimus, a L'Oreal veteran has become CEO just as vaccinations alter the landscape again, prompting not only a return of products like mascaras but other changes the firm may have to adapt to as people try to break with the crisis.
- GlobeNewswire
L'OREAL: Disclosure of total number of voting rights and number of shares in the capital at April 30, 2021
Société anonyme au capital de 112 133 283 euros Siège social : 14, rue Royale, 75008 Paris 632 012 100 R.C.S. Paris Legal Entity Identifyer : 529900JI1GG6F7RKVI53 Disclosure of total number of voting rights and number of shares in the capital at 30 April 2021 Pursuant to article L-233-8 II of the French “Code de Commerce” and 223-16 of the AMF's General Regulations: Total number of shares 560,666,415 Number of real voting rights (excluding treasury shares) 560,666,415 Theoretical number of voting rights 560,666,415 (including treasury shares*) (*) pursuant to article 223-11 of the AMF’s General Regulations About L'Oréal L’Oréal has devoted itself to beauty for over 110 years. With its unique international portfolio of 35 diverse and complementary brands, the Group generated sales amounting to 27.99 billion euros in 2020 and employs 85,400 people worldwide. As the world’s leading beauty company, L’Oréal is present across all distribution networks: mass market, department stores, pharmacies and drugstores, hair salons, travel retail, branded retail and e-commerce. Research and innovation, and a dedicated research team of 4,000 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world. L’Oréal’s sustainability commitment for 2030 “L’Oréal for the Future” sets out ambitious sustainable development objectives across the Group’s value chain. www.loreal.com CONTACTS AT L'ORÉAL Individual shareholders and market authorities Mr. Christian MUNICH Phone: +33.(0)1.47.56.72.06 christian.munich2@loreal.com Financial analysts and institutional investors Mrs. Françoise LAUVIN Phone: +33.(0)1.47.56.86.82 francoise.lauvin@loreal.com For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the Internet site for shareholders and investors, www.loreal-finance.com or the L’Oréal Finance app, alternatively, call +33 1 40 14 80 50. "This document does not constitute an offer to sell, or a solicitation of an offer to buy, L’Oréal shares. If you wish to obtain more comprehensive information about L’Oréal, please refer to the public documents registered in France with the Autorités des Marchés Financiers [which are also available in English on our Internet site: www.loreal-finance.com]. This document may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materiallyf rom those indicated or projected in these statements." Attachment Declaration at April 30 2021
